Average Co-Inventor Count = 5.34
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (11 from 4,942 patents)
2. F. Hoffmann-la Roche Ag (168 patents)
11 patents:
1. 11708344 - Flavone derivatives for the treatment and prophylaxis of hepatitis B virus disease
2. 11447489 - Dihydropyrimidinylthiazole for the treatment and prophylaxis of hepatitis B virus infection
3. 11225482 - Dihydropyrrolopyrimidines for the treatment and prophylaxis of hepatitis B virus infection
4. 11104674 - Tetrahydropyridopyrimidines for the treatment of HBV infection
5. 10093671 - 2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection
6. 10053461 - Tetracyclic 4-oxo-pyridine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection
7. 9949966 - Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection
8. 9845322 - Tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis B virus infection
9. 9637485 - 6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection
10. 9458153 - Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection
11. 9458106 - Phenyl-pyridine/pyrazine amides for the treatment of cancer